Page 3 - Programming Initiative On Antimicrobial Resistance News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Programming initiative on antimicrobial resistance. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Programming Initiative On Antimicrobial Resistance Today - Breaking & Trending Today

UKCEH to roll out COVID-19 wastewater sampling technique in new AMR project | UK Centre for Ecology & Hydrology

A new £1.25 million project, which will research the role of managing antibiotic use in combatting AMR transmission, will utilise the novel wastewater sampling technique UKCEH developed in response to the COVID-19 pandemic. This is the first time this technique will be implemented with populations outside the UK, and used to target non-COVID health questions. ....

United Kingdom , Adam Roberts , European Regional Development Fund Project , Malawi Liverpool Wellcome Trust , Health Context , Programming Initiative On Antimicrobial Resistance , University Of Bergen , Liverpool School Of Tropical Medicine , Wageningen Research , Antimicrobial Stewardship , Resistance Selection , One Health Context , Andrew Singer , Liverpool School , Tropical Medicine , Queen Elizabeth Central Hospital , Wageningen Bio Veterinary Research , One Health , Joint Programming Initiative , Antimicrobial Resistance ,

Global Antibiotics Technologies and Markets, 2018-2019 Data, 2020 Estimates & Forecasts to 2025


Share this article
Share this article
ResearchAndMarkets.com s offering.
The global market for antibiotics should grow from $44.4 billion in 2020 to reach $65.4 billion by 2025 at a compound annual growth rate (CAGR) of 8.1% during the period of 2020-2025.
The report focuses on newer drugs and innovations in chemical compounds, vaccines and biologicals, recently launched or in development. Specifically excluded from the scope of research are vector or mosquito control approaches, strategies and products; drugs used for symptomatic treatment and not for the elimination of the virus from the host; and details on manufacturers and suppliers of non-branded generics.
The antibiotics market growth outlook is positive with significant growth potential for cell wall inhibitor and protein inhibitor antibiotic drugs. There is pressure on antibiotic drug manufacturers to offer antimicrobial-resistant drugs at affordable prices. At the same time, factors such as rising di ....

United States , South Africa , Laura Wood , Glaxosmithkline Plc , A Center , Merck Co , Broad Spectrum Antimicrobials Program , Global Company Market Share Analysis , Innovative Medicines Initiative , Merck Co Inc , Funding For New Antibiotic Development , Development Of Novel Antibacterial Agents , Development Rd Investment , Pfizer Inc , International Regulation , Programming Initiative On Antimicrobial Resistance , Custom Research , Technology Background , Office Hours Call , Biomedical Advanced Research , Other Routes Of Administration , Development Authority , Drug Development , Company Profiles , E St Office Hours Call , Route Of Administration ,